Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

National Institute of Environmental Health Sciences

Use this QR code to view the newest version of this document
Use this QR code to view the newest version of this document

Your Environment. Your Health.

Publication Detail

Title: Epithelial-specific ERBB3 deletion results in a genetic background-dependent increase in intestinal and colon polyps that is mediated by EGFR.

Authors: Mantilla Rojas, Carolina; McGill, Michael P; Salvador, Anna C; Bautz, David; Threadgill, David W

Published In PLoS Genet, (2021 Nov)

Abstract: ERBB3 has gained attention as a potential therapeutic target to treat colorectal and other types of cancers. To confirm a previous study showing intestinal polyps are dependent upon ERBB3, we generated an intestinal epithelia-specific ERBB3 deletion in C57BL/6-ApcMin/+ mice. Contrary to the previous report showing a significant reduction in intestinal polyps with ablation of ERBB3 on a B6;129 mixed genetic background, we observed a significant increase in polyp number with ablation of ERBB3 on C57BL/6J compared to control littermates. We confirmed the genetic background dependency of ERBB3 by also analyzing polyp development on B6129 hybrid and B6;129 advanced intercross mixed genetic backgrounds, which showed that ERBB3 deficiency only reduced polyp number on the mixed background as previously reported. Increased polyp number with ablation of ERBB3 was also observed in C57BL/6J mice treated with azoxymethane showing the effect is model independent. Polyps forming in absence of ERBB3 were generally smaller than those forming in control mice, albeit the effect was greatest in genetic backgrounds with reduced polyp numbers. The mechanism for differential polyp number in the absence of ERBB3 was through altered proliferation. Backgrounds with increased polyp number with loss of ERBB3 showed an increase in cell proliferation even in non-tumor epithelia, while backgrounds showing reduced polyp number with loss of ERBB3 showed reduced cellular proliferation. Increase polyp number caused by loss of ERBB3 was mediated by increased epidermal growth factor receptor (EGFR) expression, which was confirmed by deletion of Egfr. Taken together, this study raises substantial implications on the use of ERBB3 inhibitors against colorectal cancer. The prediction is that some patients may have increased progression with ERBB3 inhibitor therapy, which is consistent with observations reported for ERBB3 inhibitor clinical trials.

PubMed ID: 34843459 Exiting the NIEHS site

MeSH Terms: Adenomatous Polyposis Coli Protein/genetics; Animals; Cell Proliferation/genetics; Colon/metabolism; Colon/pathology; Colonic Polyps/genetics*; Colonic Polyps/pathology; Colonic Polyps/therapy; Colorectal Neoplasms/genetics*; Colorectal Neoplasms/pathology; Colorectal Neoplasms/therapy; Disease Models, Animal; ErbB Receptors/genetics*; Gene Expression Regulation, Neoplastic/genetics; Gene Silencing; Humans; Intestinal Mucosa/metabolism; Intestinal Mucosa/pathology; Intestinal Polyps/genetics*; Intestinal Polyps/pathology; Intestinal Polyps/therapy; Mice; Receptor, ErbB-3/antagonists & inhibitors; Receptor, ErbB-3/genetics*

Back
to Top